Insmed Inc (INSM)

[ED20332]

Mr. Tim Ryan at the Trout Group.


Talked w/ IR today.
by: retired_by_31 (29/M/West Michigan) 03/29/06 11:05 am
Msg: 81543 of 81550

After many failed attempts to talk with Baxter Phillips, I wrote a letter to several other people at Insmed, explaining Baxter's inability to return telephone calls etc. This morning, I received a very apologetic telephone call from a Mr. Tim Ryan at the Trout Group. Mr. Ryan is very open and very nice to converse with. The following is what I learned:

There have been no orders submitted for IPlex yet. INSM has completely hired senior management for the sales efforts. INSM has assembled roughly half of its on-the-ground sales force. INSM will launch IPlex probably in May, in between the two large endocrine meetings, which are scheduled for the end of April and beginning of June. INSM probably will use one or both of those endo meetings as a PR springboard for the launch. INSM has not set a price for IPlex yet, but probably will price at or slightly above TRCA's drug. There is no time frame set for European approval and INSM is still considering whether to partner in Europe.

Mr. Ryan informed me that Baxter Phillips is transitioning out of his position. Mr. Ryan apologized for Mr. Phillips lack of communication (with me) and said that it simply should not have happened.

if you would like to chat with Mr. Ryan here is how:
212-477-9007 ext 24
or
[e-mail]

very nice engaging fellow